Catalyst Funds Management Pty LTD Aurinia Pharmaceuticals Inc. Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 5,200 shares of AUPH stock, worth $43,316. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,200Holding current value
$43,316% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding AUPH
# of Institutions
207Shares Held
58.3MCall Options Held
914KPut Options Held
1.35M-
Black Rock Inc. New York, NY9.27MShares$77.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY8.2MShares$68.3 Million1.0% of portfolio
-
Tang Capital Management LLC San Diego, CA7.23MShares$60.2 Million4.52% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$33.1 Million2.22% of portfolio
-
State Street Corp Boston, MA2.95MShares$24.5 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.18B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...